<li>Founded in 2013 by a team of scientists, veterinarians, and engineers</li><li>Successfully raised over $10 million in funding</li><li>Now operates a global plant-based blood distribution network</li><li>Helping more than 2,500 patients in more than 50 countries</li>
<li>Founded in 2014 by a group of entrepreneurs, scientists, and healthcare professionals</li><li>Successfully raised over $5 million in total investor funding</li><li>Successfully completed its first Phase I clinical trial in 2016</li><li>Successfully completed its first Phase II clinical trial in 2019</li><li>Now in its final Phase III clinical trial</li><li>Looking to bring plant-based blood to the market in 2020</li>
<li>Founded in 2013 by two entrepreneurs</li><li>Provides plant-based blood products to the global market</li><li>Successfully raised total $19 million in funding</li><li>Operates out of a state-of-the-art facility in California</li><li>Has a potential to become the leading plant-based blood producer</li>
<li>Founded in 2014 by two scientists and their team of engineers </li><li>Provides a plant-based blood product that is 100% natural and free from any artificial ingredients </li><li>Has been featured in The New York Times, Wall Street Journal, and other leading publications </li><li>Has received multiple awards, including a travel award from the American Society of Hematology </li><li>Is currently in the development stage of a new product that will offer a more personalized blood transfusion experience</li>
<li>Founded in 2014 by a team of students at the University of Utah</li><li>Successfully raised $3 million in Series A funding in 2018</li><li>Launched the first ever plant-based blood product in 2019</li><li>Continues to grow their product line and make large contributions to the field of plant-based blood</li>
